$BMEA 4/A SEC Filings

Filed On	Filing
06 Apr 2023	Form 4/A: A2A Pharmaceuticals, Inc., 10% owner Sold 200,000 shares ($6.25M)
10 Feb 2023	Form 4/A: Erdtmann Rainer M, Director Bought 8,400 shares ($143K)

Comments